Papillomavirus: vaccination widespread in universities since the beginning of the 2023 school year

Papillomavirus: vaccination widespread in universities since the beginning of the 2023 school year

By generalizing the vaccination campaigns against the papillomavirus in all colleges in France, the President of the Republic hopes to achieve a vaccination coverage of 80% by 2030. But if this vaccine is the most effective means of preventing some cancers, it is still a victim of received ideas.

France intends to catch up on papillomavirus vaccination. Emmanuel Macron has just announced the generalization of vaccination campaigns in all French colleges. From the beginning of next school year, fifth graders will be able to receive the vaccine. The measure, tested for two years in the Grand-Est region, has already achieved very satisfactory results. The vaccination rate for fifth graders went from 9% to 27% in the first year and from 14% to 31% in the second year.

Nationwide, the vaccination rate is 37% for girls and only 9% for boys. This low vaccination coverage favors the circulation of the papillomavirus, which is responsible for more than 6,000 cases of cancer of the cervix, otolaryngological regions, penis or anus each year. France hopes that 80% of the affected population will be vaccinated within seven years. Consider current figures from countries like Sweden, the UK, and Australia.

The papillomavirus vaccine victim of ideas received in France

In France, this vaccine and the virus it fights are victims of received ideas that slow down the generalization of prevention and screening campaigns.

Many see it first a vaccine reserved for girls, but men are just as likely to get or pass it on. Especially since HPV (Human Papillomavirus) is also transmitted during oral sex and sometimes resists condoms. The age of vaccination is also poorly understood. Today, national vaccination campaigns are aimed at 11-14 year olds, but it is possible to catch up on vaccination up to the age of 19. Ideally, it is best to receive the vaccine before first sexual intercourse to avoid the risk of a previous infection. However, this is not essential: if the person has not contracted the virus, the vaccine will work normally.

Papillomavirus is the cause of 2% of cancers each year. It is estimated that all cervical cancers and 90% of anal cancers are caused by this infection. Currently, in France, 70% of people will be affected by this virus at least once in their life and 10% of them are still carriers of lesions after two years. By comparison, in Australia, only 1.5% of young women aged 18-24 were carriers in 2015, up from 22% in 2015.

Within 15 years, uterine cancer may even be eradicated there.

Source: Madmoizelle

Leave a Reply

Your email address will not be published. Required fields are marked *

Top Trending

Related POSTS